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The I  region of the major histocompatibility complex (H-2)  of the mouse controls 
a  variety of immunologically related phenomena, including  immune responsiveness 
and cellular interactions among lymphocytes and antigen-presenting cells (1-4). The 
only gene products from the I  region that have been identified by immunochemical 
techniques  are  the  Ia  (I  region-associated)  antigens  (5).  Evidence  involving  the 
inhibitory effects of anti-Ia antibodies suggests that these Ia antigens may mediate at 
least some of the immunological phenomena controlled by the genes of the I  region 
(6,  7). 
The I region is genetically complex and can be divided into at least five subregions, 
I-A,  I-B,  I-J,  I-E,  and I-C,  by recombinational analysis (8).  Loci that map to the I-A 
and I-E subregions have been shown to encode the Ia antigens, which appear to be 
highly  polymorphic by serological  analysis  and  are expressed predominantly  on  B 
lymphocytes  (9,  10).  The  Ia  molecules  are  integral  cell  surface  gtycoproteins  and 
consist  of  two  distinct,  noncovalently  associated  potypeptide  chains:  A~  and  A~ 
compose the Ia A molecules immunoprecipitated using anti-A subregion sera, whereas 
E~ and E~ constitute the Ia E molecules isolated using anti-E subregion reagents. The 
larger polypeptides, A~ and  E~, have apparent  molecular weights of 33,000-35,000, 
whereas  the  smaller  polypeptides, A/~ and  Ep,  have apparent  molecular weights  of 
27,000-29,000  by sodium  dodecyl  sulfate-polyacrylamide gel  electrophoresis  (SDS- 
PAGE) .1 
These Ia polypeptides have been partially characterized by us and by others  (11- 
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15).  Using the techniques  of partial  N-terminal,  amino acid sequencing and  high- 
pressure  liquid  chromatography  (HPLC)  tryptic peptide  mapping, we have shown 
that the E, polypeptides have striking homology with human p34 chains, at least at 
their N-termini;  that  the E~  and E k polypeptides are very similar,  if not  identical; 
that the A,,, A#, and E~ polypeptides of various haplotypes differ by multiple amino 
acid substitutions; and that the genes encoding these proteins map to the H-2 complex 
(16-20). 
Two-dimensional electrophoretic analyses of Ia immunoprecipitates by Jones et al. 
(21) have shown that a third protein, designated the invariant polypeptide or Ii, which 
is basic in character and appears to be nonpolymorphic, specifically co-immunopre- 
cipitates with  Ia molecules. 2 McKean and his coworkers (22)  have recently demon- 
strated that the interaction of this protein with Ia molecules is not an artifact of the 
isolation  procedures.  Proteins  that  appear  to  be  the  counterparts  of Ii  have  been 
recognized in man and the rat (23, 24). 
In this paper, we investigate the relation of  this invariant protein to the polypeptides 
that we have previously partially characterized and we extend our genetic mapping 
studies of the Ia polypeptides. We show that  Ii does co-immunoprecipitate with our 
Ia  molecules,  that  the  strength  of its  interaction  with  Ia  polypeptides  varies with 
haplotype, and that it is not a precursor of the A,, Ap, E~, or E# polypeptides. We also 
demonstrate that the polypeptides we have previously characterized are contaminated 
with  very little,  if any, invariant  protein.  Further,  we have used our HPCL tryptic 
peptide  map  technique  to  formally  map  the  genes  encoding  the  A,,  Ap,  and  E# 
polypeptides to the I-A subregion using recombinant and F1 hybrid mice. 
Materials and Methods 
Mice.  All mice used were obtained from the mouse colonies of Drs. McDevitt and Frelinger. 
Antisera.  Monoclonal anti-A  k antibodies were derived from the hybridoma cell line  10-2.16 
(The Sulk Institute, San Diego, Calif.). The following atloantisera were used: A.TL anti-A.TH 
(A~), C3H anti-C.SW  (A~), and B10XHTI)F1 anti-B10.A(3R)  (Ek). Their specificities  have 
been discussed previously (16, 17,  19). 
Isolation of Ia Antigens 
RADIOLABELING.  The  procedures  for radiolabeling and  isolating Ia antigens  have been 
described in detail elsewhere  (16). Briefly, splenic lymphocytes at a contzentration  of 5 ×  107 
cells/ml (including erythrocytes) were cultured for 5-9 h in Hanks' balanced salt solution with 
10 mM  Hepes, 5% dialyzed fetal calf serum, and  radiolabeled amino acids  (New England 
Nuclear, Boston, Mass.). The cells were lysed at the same concentration with TST buffer (0.01 
M Tris, 0.15 M NaCI, pH 7.3, and 0.5% Triton X-100) and, after centrifugation, the supernate 
(cell lysate) was stored at -70°C. 
IMMUNOPRECIPITATION.  Antigen-antibody  complexes  were  isolated  using  formalin-fixed 
Staphylococcus aureus Cowan  I  strain  (SAC)  as described by Cullen  and  Schwartz  (25). The 
radiolabeled Ia antigens were eluted from the SAC by boiling for 2 rain in  "elution" buffer 
(0.063 M Tris, pH 6.8, 2% 2-mercaptoethanol, and 2% SDS). In studies  involving immunopre- 
cipitation in  the presence of 0.5% SDS,  the washing buffer was TST buffer containing 0.1% 
SDS. 
ONE-mMENSIONAL 0D)-SDS-PAGE.  Radiolabeled Ia polypeptides in elution buffer (100-300 
gl) were separated on 10% polyacrylamide gels (26) and were eluted from 1-mm gel slices using 
0.0i% SDS.  In duaMabel studies,  aH and ~S dpm were calculated directly by a  Beckmann 
Lsg000 scintillation counter (Beckman Instruments, Inc,, Fullerton, Calif.),  using experimen- 
tally determined quench curves~ 
This polypeptide has been alternatively designated A, (40) because it is encoded by a gene located 
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HPLC T(yptic Peptide Mapping. The procedure used is essentially that described by McMillan 
et al. (18). Each polypeptide was mixed with 0.25 mg porcine immunoglobulin and lyophilized. 
The  protein  was  then  reduced,  alkylated,  and  digested  with  L(tosylamide-2-phenyl)-ethyl- 
chloromethyl-ketone(TPCK)-trypsin  (Worthington Biochemical Corp.,  Freehold,  N.J.),  and 
the resulting tryptic peptides were analyzed by HPLC using either a 25-cm Zorbax-CN column 
(DuPont  Instruments, Wilmington, Del.;  Figs.  5-7 and 9)  or a  25-cm Zorbax-ODS column 
(Fig. 8) at 49°C, and a phosphate/acetone solvent system. 0.5-ml fractions were collected every 
30 s. 
Two-Dimensional (2I)) Electrophoresis 
The samples were loaded at the anode and separated  in the first  dimension by isoelectric 
focusing  (IEF)  and  in  the  second dimension  by SDS-PAGE. This  is  a  modification of the 
methods described by O'Farrell (27, 28). 
Fms'r mMENSlON.  The IEF gel mixture was made as follows: 0.8 ml twice-distilled water, 1.0 
ml  10% (vol/vol) Triton X-100 solution, 0.84 ml stock acrylamide solution (100 ml contained 
28.38 g acrylamide, 1.62 g bisacrylamide [Bio-Rad Laboratories, Richmond, Calif.])  and LKB 
ampholines (200 #1, pH 3.5-10; 70 #1, pH 9-11; 70 #1, pH 2.5-4) were added to 2.75 g urea. 8.5 
#I  ammonium  persulfate  and  6.3  /~I  N,N,N',N'-tetramethylethylenediamine  were  used  for 
polymerization. The solution was overlayed using 8 M urea and "lysis" buffer (9.5 M urea, 2% 
Triton X-100, 1.6% ampholines, pH 5-7, 0.4% ampholines, pH 3.5-10, and 5% 2-mercaptoeth- 
anol). After 2 h, the overlay solution was removed and, without 'prefocusing' each sample (in 
lysis buffer), was loaded at the anode and overlayed with  10 #1 of a solution containing 8 M 
urea, ampholines (0.2% pH 3.5-10, 0.8% pH 5-7), and 0.5 mg/ml each glutamic and aspartic 
acids. The samples were subjected to IEF at 500 V  for 10-12 h. The gels to be analyzed in a 
second dimension were extruded into a solution containing 0.18 M Tris, pH 6.8, 30% glycerol, 
7% SDS, and  12.5% 2-mercaptoethanol. 
SECOND mMENSION.  The IEF gels were sealed on top of the stack of an SDS slab gel  (10% 
polyacrylamide) and electrophoresed as described by O'Farrell (27). The gels were prepared for 
fluorography using the method of Bonner and Laskey (29) and were then dried and exposed to 
preflashed Kodak XR-5 film (Eastman Kodak Co., Rochester, N. Y.; 30). 
METHIONINE pEPTIDE MAPS OF THE INVARIANT POLYPEPTIDE.  The A  s  and E  k molecules were 
sequentially  immunoprccipitated from a [35S]mcthioninc-labclcd B 10.HTT cell  lysatc  and run 
on ID-SDS-PAGE.  The proteins of ~31,000 tool wt (intermediate between a and fl) were 
mixed with carrier,  reduced, alkylatcd,  and precipitated  with trichloroacctic  acid (TCA). The 
precipitates  were dissolved  in lysis  buffer  and subjected  to  IEF. The gels  were sliced  into  2-ram 
discs  and incubated in  0.5  ml containing 0.05 M  ammonium  bicarbonate and 0.05% SDS. 10% 
aliquots  were counted, and the remaining 90% of  the relevant  fractions  wcrc mixed with 0.25 
nag porcine gammaglobulin  that had bccn previously reduced and alkylated. After TCA 
precipitation, the proteins were digested with trypsin,  and the pcptides were mapped using 
HPLC. 
Results 
I D-SDS-PAGE Analyses  of aSS  - and all-labeled Ia Immunoprecipitates.  In our character- 
izations of Ia polypeptides by partial amino acid analyses and HPLC tryptic peptide 
mapping,  we  had  previously  used  tritiated  amino  acids.  In  contrast,  in  the  2D 
electrophoresis studies by Jones  (31)  and others  (32),  [aSS]methionine was often used 
to facilitate analysis by autoradiography. To compare both types of incorporation, we 
labeled  B10.A(1R)  and  B10.HTT  spleen  lymphocytes with  [SH]phenylalanine  and 
[aSS]methionine.  Conventional  immunoprecipitation  in  TST  buffer  using  anti-Ia 
serum,  followed  by analysis  on  1D-SDS-PAGE,  gave  the  profiles  shown  in  Fig.  1, 
panels i and iii. The Aa and At~ polypeptides that we have previously isolated are the 
predominant  species  in  the 3H-labeled  immunoprecipitate,  whereas  a  third  species, 
having an apparent molecular weight intermediate between the a  and fl polypeptides, McMILLAN ET AL.  939 
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Fie.  1.  Portions of SDS-PAGE patterns (10% reducing gels) ofA  a molecules immunoprecipitated 
from  a  BI0.A(1R)  cell  lysate  (panels  i  and  ii),  and  A a molecules  immunoprecipitated  from  a 
B10.HTT  cell  lysate  (panels  iii  and  iv).  The  radioactivity  is  plotted  on  the  ordinate;  (  ) 
represents incorporated [aH]phenylalanine;  (.  •  .)  denotes [aSS]methionine. Migration distance is 
plotted on the abscissa. The buffer used during the immunoprecipitation procedure was TST in 
panels i and iii, and TST containing 0.5% SDS in panels ii and iv. 
is the dominant species when [a~S]methionine is used as radiolabel. We have confirmed 
that this is the invariant polypeptide, first described by Jones et al.  (21), by our 2D 
gel  analyses  reported  later  in  this  paper.  In  all  our  [~S]methionine-labeled  Ia 
immunoprecipitates (both A and E), we find that this polypeptide is always present 
and always appears to be the predominant species. 
To determine whether the binding of this invariant protein to Ia molecules is as 
strong as the association between the a  and fl polypeptides, immunoprecipitations 
were carried out in the presence of 0.5% SDS. Such conditions have been reported to 
dissociate actin from transplantation antigens (33). Fig.  1, pane[ ii shows the analysis 
of the A k molecule in  which  the  invariant  polypeptide is  clearly absent  when  the 
immunoprecipitation  is  carried  out  in  TST  buffer containing 0.5%  SDS.  Similar 
results have been obtained by Moosic et al. (22), using pyrrolidinone. Panel iv shows 
the analysis of the A" molecule in the presence of SDS, in which the amount of the 
invariant polypeptide has been reduced only slightly. We conclude, therefore, that Ii 
can be tightly bound at least to some Ia molecules. 
2I) Electrophoretic Analyses of Ia Molecules and Isolated Ia Polypeptides.  To determine 
whether the invariant protein is a contaminant of any of the Ia polypeptides that we 
have partially sequenced or peptide mapped, we isolated polypeptides from prepar- 
ative  1D-SDS-PAGE gels by our usual method, submitted them individually to 2D 
electrophoresis, and  compared  them  to  a  2D  analysis  of the  appropriate  total  Ia 
immunoprecipitate. Fig. 2 shows the fluorographs of the 2D gels obtained from nil- 
and 35S-labeled total immunoprecipitates of the A s and E k molecules. Small fractions 
of the immunoprecipitates were also submitted  both to analytical SDS-PAGE and 
IEF, and the distribution of radiolabel was determined by scintillation counting. The 
familiar radioactivity profiles obtained from  1D-SDS-PAGE gels are illustrated on 
the right in Fig. 2 and show a 3~S-rich peak, Ii, lying between the Ia polypeptides. The 
IEF  radioactivity profiles, shown  above the  appropriate  fluorograph,  demonstrate 
that  the  aSS-rich  polypeptide has  a  pI  of ~8,  and  is  the  same  for the  A 8 and  E k 
molecules. 
Fig. 3 shows sections of the 2D gels of isolated Ia polypeptide chains. Panel i shows 
the analysis of ~ 1.7% (~5 ×  103 cpm/-3  ×  105 cpm) of the samplesE  d andES,  whose 940  STRUCTURE OF  MURINE Ia ANTIGENS 
Fro.  2.  Fluorographs of 2D gels of A" molecules (top) and E  k molecules (bottom) immunoprecip- 
itated from BI0.HTT spleen cell lysates. The SDS-PAGE pattern of the appropriate immunopre- 
cipitate  is plotted  to  the  right  of each  fluorograph  and  the  IEF pattern  is shown  above  each 
fluorograph.  (  )  represents incorporated  [~H]phenylalanine and [3H]tyrosine, (.  • -) indicates 
[~S]methionine. pH is denoted by (° • ° "). 
partial  amino  acid  sequences  were  reported  by McMillan  et al.  (17).  The invariant 
polypeptide  was  absent  from  both  samples.  Panels  ii  and  iii  show  the  analyses  of 
isolated  SH-  and  ~S-labeled  A],  A~,  E~,  and  E~  polypeptides.  They  were  isolated 
initially  from  1D-SDS-PAGE  gels in  a  manner  identical  to that  used  for our HPLC 
tryptic  peptide  mapping.  Only  A~  and  E~  show  slight  contamination  with  the 
invariant  polypeptide.  Panel  iv shows the result  of analyzing  all the  radioactivity  of 
molecular weight  intermediate  between the Ia polypeptides  for both the A  and the E 
immunoprecipitates.  A  large  amount  of invariant  polypeptide  is  present  in  each. 
Peptide  mapping  of the  acidic  polypeptide  in  the  left  panel  showed  that  its  tryptic 
peptides  eluted  in a  manner  identical  to those of the A]  polypeptide,  which  we have 
previously characterized  (panel ii). Because this polypeptide is more basic and smaller 
in  molecular  weight  than  A~,  we  conclude  that  it  is  probably  an  incompletely 
processed a-chain  lacking some (or all)  of its carbohydrate  moietie(s).  By analogy,  in 
gel  iv, the  acidic  polypeptide  in  the  right  panel  is smaller  in  size and  slightly  more McMILLAN  ET  AL.  941 
FIo.  3.  Portions of fluorographs of 2D gels of Ia polypeptides, previously isolated by immunopre- 
cipitation and SDS-PAGE..The  identity of each chain is indicated on the fluorograph.  In panel i, 
the polypeptides were isolated  from a  B10.D2  cell lysate.  [aH]alanine,  tyrosine, valine, isoleucine, 
phenylalanine,  leucine,  and  proline were used  as  radiolabels.  The  partial  N-terminal  amino acid 
sequences of these proteins has been reported in reference 17. In panels ii, iii, and iv, the polypeptides 
were isolated from a B 10.HTT cell lysate. [SH]phenylalanine and tyrosine and [aSS]methionine were 
used  as  radiolabels.  In  panel  iv,  proteins  of molecular  weight  intermediate  between  As(E,,)  and 
Ap(Ep)  are shown in the left (right) fluorograph. 
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Fro.  4.  Diagrammatic  representations  of portions  of the  fluorographs  in  Fig.  2,  indicating  the 
various  polypeptide  chains.  Black  spots  represent  proteins  for  which  we  have  obtained  tryptic 
peptide  map  and  partial  N-terminal  amino acid sequence data.  Stippled  spots represent proteins 
that we have analyzed by tryptic peptide mapping. 
basic than the E~ polypeptide (panel iii), which suggests that it is an incomplete form 
of the E~ polypeptide. 
In  Fig.  4,  the  schematic diagrams  depict  portions  of the  2D  gels  in  Fig.  2  and 
summarize the results shown in Fig. 3. 
Comparative HPLC  T~yptic Peptide  Mapping  on  [aH]phenylalanine-labeled  Polypeptides 
Isolated by  ID-SDS-PAGE.  Having ascertained that the proteins we have partially 
chemically characterized  contain little or no  invariant  polypeptide, we  have  used 942  STRUCTURE OF MURINE Ia ANTIGENS 
HPLC to analyze the radiolabeled tryptic peptides derived from Ia polypeptides and 
have  genetically  mapped  the  loci  encoding  the  A~,  A•,  and  E~  chains.  Similar 
experiments  have  been  reported  by  other  laboratories  (34-38)  in  which  tryptic 
peptides were analyzed using ion-exchange chromatography and IEF. 
One of the major advantages of HPLC over conventional ion-exchange chromato- 
graphy is that its extreme reproducibility enables us to compare many peptide maps 
run over a period of several weeks. In contrast, only two polypeptides analyzed as a 
mixture, one a4C-labeled, the other ~H-labeled, can  be compared  by ion-exchange 
chromatography. 
In this study, we have used [~H]phenylalanine as the radiolabel for three reasons: 
(a)  phenylalanine can be obtained with high specific activity (often >I00 Ci/mM), 
(b) it is readily biosynthetically incorporated into Ia polypeptides, and (c) it is a more 
common amino acid than tyrosine and  less  common than leucine. In  this way, we 
hoped to observe more tryptic peptides than in our previously reported studies using 
[3H]tyrosine; however, we did  not  wish  to obtain  too many peptides in  case small 
differences in peptides were obscured by the overlapping of too many peptides, e.g., 
the E~ polypeptide has  7 tyrosine-,  15 leucine-, and 9 phenylalanine-labeled tryptic 
peptides. 
In  this  peptide  map  study,  we  radiolabeled  with  a  single  amino  acid  (usually 
phenylalanine) because we wished to compare the tryptic maps of Ia polypeptides. 
Using this method, small differences in two very similar polypeptides can be demon- 
strated if radiolabeled peptides are involved. On the other hand, small dissimilarities 
may  go  undetected  if the  structural  diversity resides  only  in  unlabeled  peptides. 
Nevertheless, this approach, using a  single amino acid as label, is less complex than 
incorporating several radiolabeled amino acids simultaneously into Ia proteins. We 
have observed that the efficiency of biosynthetic incorporation of radiolabels into Ia 
polypeptides varies both with the individual mouse used and the particular batch of 
amino  acid;  moreover, the relative specific activities of amino  acids  vary between 
batches. Therefore, to avoid the necessity of an independent control to measure the 
relative incorporation of different amino acids into different lymphocytes, we chose to 
label each preparation with only one amino acid. 
Fig. 5 shows the phenylalanine-labeled tryptic peptide maps obtained for A~ and 
At~ polypeptides. Figs. 6 and 7 show the peptide maps used to map the Et~ polypeptides. 
HPLC Mapping  of Polypeptides  Isolated  by  1D-SDS-PAGE  and IEF.  To  determine 
whether  the  invariant  protein  is  structurally  related  to  the  Ia  polypeptides,  we 
compared  the  [~SS]methionine-labeled  and  the  [3H]phenylalanine-labeled  peptide 
maps of A~, A~, EL, and E~ with those of Ix. 
The procedure for isolating the Ii protein is more complex than for isolating the A,, 
A~,  E~, and  EO polypeptides, which  can be obtained directly from  1D-SDS-PAGE 
gels.  The slices of SDS gels containing the invariant polypeptide are contaminated 
with an acidic polypeptide (probably incompletely processed forms of A~ and E~; see 
Fig. 3, panel iv). Fig. 8, panel ii illustrates the results of peptide mapping the proteins 
of ~31,000  mol  wt  (intermediate  between  A~  and  Ap)  containing  the  invariant 
polypeptide and  a  form of the A,  polypeptide. When  compared with  panel  i,  the 
peptide map of pure A~, peptides from both A, and the invariant polypeptide are 
clearly visible. Therefore, we obtained pure invariant  polypeptide from A s and  E k 
immunoprecipitates first by separating the protein of the correct molecular weight on McMILLAN  ET  AL.  943 
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1D-SDS-PAGE gels and then by isolating the basic polypeptide from an IEF gel. The 
[35S]methionine-labeled tryptic peptide maps of these two proteins are shown in Fig. 
9  and appear to be identical.  In these peptide maps of Ii, eight  methionine-labeled McMILLAN  ET  AL. 
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The  polypeptides  were  separated  using SDS-PAGE  and  IEF.  Radioactivity  is  plotted  on  each 
ordinate, the fraction number is plotted on the abscissae. The organic solvent gradient is the same 
as that used for the A,, peptide maps. 
peptides are separated by the column, whereas in the maps ofA~, Ap, E~, and E~, only 
2-3 methionine-labeled peptides are obtained. In contrast, in the [3H]phenylalanine- 
labeled tryptic peptide maps, the invariant protein possesses only two labeled peptides, 
whereas the Ia polypeptides yield 9-11  labeled peptides. Based on this evidence, we 
conclude that  Ii  is not a  precursor of the A~, At~  , E=, and E~ polypeptides, and that 
none of the A~, A~, E~, or E~ polypeptides is a precursor of Ii. 
Discussion 
The Invariant Polypeptide, a Methionine-rich Protein That Specifically Co-immunoprecipitates 
with Ia Molecules, in an Association Whose Strength  Varies with Haplotype, Is Not a Precursor 
of Either the A~, Ap, E~, or E, Polypeptides.  Our electrophoretic analyses of Ia immu- 
noprecipitates using [3H]phenylalanine and  [aSS]methionine show that a  third poly- 
peptide,  Ii,  described  originally by Jones  et  al.  (21),  is  always  isolated  under  the 
normal  immunoprecipitating  conditions  described  by  Cullen  and  Schwartz  (25). 
Under partially denaturing conditions (0.5% SDS), however, the association of Ix with 
A s molecules is much stronger than with A k molecules. 
The amino acid composition of the invariant polypeptide is unusual. It has at least 
eight methionine-labeled tryptic peptides, in contrast to the Ia polypeptides, which 
have 2-3 methionine-labeled peptides  (a more common number for proteins in the 946  STRUCTURE OF MURINE Ia ANTIGENS 
30,000-mol wt range). The Ii polypeptide has only two phenylalanine-labeled tryptic 
peptides, compared to the 9-11  labeled peptides obtained from the Ia polypeptides, 
and as judged from its pI (~8), it also has numerous lysine and/or arginine residues. 
It  is  not  surprising,  therefore, that  our peptide  map  studies  demonstrate  that  the 
invariant polypeptide is not a precursor of any Ia polypeptide, A~, Ap, E~, or E~. 
The significance of the interaction of the invariant polypeptide with Ia molecules 
is not understood at present, but it may play an as yet undefined physiological role in 
the  functioning  of Ia  molecules  in  the  immune  response.  To  date,  experimental 
evidence suggests  that  Ii  is  not  polymorphic and,  therefore, no conclusions can  be 
drawn  about  the  chromosomal  location of the  gene encoding the  invariant  poly- 
peptide. 
The  Genes Encoding  the  Ia  Polypeptides  Have  Been Mapped  Using  HPLC  Comparative 
T~yptic Peptide Analyses 
THE GENES  ENCODING  THE  Aa, A8 ,  AND E,8 POLY'PEPTIDES  MAP TO THE  I-A SUBREGION.  In 
Fig.  5,  we  have  compared  the  phenylalanine-labeted  peptide  maps  of  A.TL, 
BI0.A(4R), and B10.A(1R), and have shown that theAo  k andA~  polypeptides appear 
identical to one another but differ from the A~ and A  a polypeptides of the H-2  b and 
H-2  ~ haplotypes of B10 and A.TH. The genes encoding the A~ and A  a polypeptides 
must therefore lie to the left of the I-B subregion and to the right of the H-2K region, 
i.e., in the I-A subregion. A new subregion, I-N, located between H-2K and I-A, has 
recently been  defined  by  the  proliferative response  of the  A.TL  strain  in  mixed 
lymphocyte reactions  (39). Our peptide map data on the A.TL Ia molecules show 
that both the A~ and Ap polypeptides appear identical to those of the H-2  k haplotype 
and,  therefore,  the  genes  encoding  them  must  map  to  the I-A  and  not  the  I-N 
subregion. 
Several laboratories have reported that the gene encoding the Et~ polypeptide maps 
the I-A subregion, which agrees with our data (34-36, 38, 40). In Fig. 6, the peptide 
map of E~ from B10.A(5R)  differs from those of B10.A(1R)  and A.TL (which are 
identical to each other), and from those of B10.HTT and B10.S(9R)  (which also are 
indistinguishable from one another). Thus, E a varies depending on the haplotype of 
the I-A and not the I-E subregion. To formally prove the gene encoding E a lies in the 
I-A subregion, we have also examined the structure of the E~ polypeptide in strains 
having the same I-A subregion (LA b) but differing in the origin of their I-E subregions 
(I-E k  and  LEa).  Because  of the  lack  of a  recombinant  mouse  having  an  I-AbE a 
haplotype, we have used an F1 hybrid mouse having the H-2  bid haplotype. This Fa 
mouse  would  be  expected  to  express on  its  cell  surface  the  hybrid  Ia  molecules, 
E~Ead  d +  E~E~d  b  (38,  40,  41).  Our  experiment  is  designed  to  answer  the  following 
d  b  question: is this E~ polypeptide in the E~Ea molecule the same as or different from the 
E~ polypeptide in a B10.A(5R) mouse (Ek~E~)? Fig. 7 shows that these two polypeptides 
are, in  fact, identical, and formally proves that  the E~ polypeptide is encoded by a 
gene mapping to the I-A subregion. 
THe GENE ENCODING  THE  E~  POLYPEPTIDE  MAPS  TO  THE  I-E SUBREGION.  Because the 
Ia molecules, E~Ea, are immunoprecipitated using anti-E subregion reagents, the E~ 
polypeptide must map to the I-E subregion, as the E a polypeptide maps to the I-A 
subregion. Although 2D electrophoresis studies by Jones (31) indicate that E d differs 
from E k, we found no detectable differences between the [3H]phenylalanine-labeled McMILLAN ET AL.  947 
peptide maps of E~ and EL from B10.D2 and B 10.A(5R) strains. This agrees with the 
data of Silver et al. (42), who analyzed the peptides using IEF. Cook et al. (14) report 
93% identity of tryptic peptides when multiple amino acids are used as radiolabels. 
The E~ Polypeptides of the 1-1-2  k'b" Haplotypes Are More Chemically Similar to Each Other 
than to the E# Polypeptides of the H-2 a Haph,type.  Fig. 6 illustrates that the EO polypeptide 
from B10.A(5R),  BI0.A(IR), A.TL, BI0.HTT, and BI0.SOR)  have all but one of 
their  phenylalanine-containing peptides  in  common  (8  out  of 9),  and  that  each 
haplotype appears to have one unique peptide per haplotype (shaded black). Because 
peptide mapping tends to exaggerate differences between homologous proteins, this 
means that the E~  ~'b polypeptides are very similar; in fact, the E~ and E~ chains are 
indistinguishable by  2D  electrophoresis, although  they are  chemically distinct by 
peptide mapping. In contrast, the E~ chain shares only 6 our of 9 of its phenylalanine- 
laheled peptides with the E~  '~'b polypeptides (Fig.  7), which agrees with our previous 
studies using tyrosine* and [eucine-labeled proteins (18). 
This observation correlates beautifully with the observations of Lerner et al.  (43), 
who have made a monoclonal antibody that reacts with Ia molecules composed of E~ 
and E~  'b", but  not E, and E~.  It also is consistent with the serological work on Ia 
hybrid molecules of Lafuse et a]. (44), who have shown that E~ and E~ share, together 
with E~, the determinant defining the specificity Ia.22. The E~  'b'~ polypeptides do not 
express specificity Ia.23, which resides on the E~ chain. 
E B Polypeptides in Ia Hybrid Molecules in F1 Mice  Turn Over at Different Rates.  Fig.  7 
illustrates that in the peptide map of the H-2  bxa mouse the ratio of peptides unique to 
E~ compared  to  those  unique  to E~  is  not  the  1:1  ratio  that  would  be  expected 
assuming simple  gene-dosage effects. The E~  polypeptide  is  more  biosynthetically 
labeled than the E~ chain, and we have confirmed this observation independently by 
2D electrophoresis, which showed that the E,~ spot was much more intense than the 
E~ spot.  This  differential labeling  is  not  due  to  differences in  the  phenylalanine 
content of these proteins, because E~  and E~  are  highly homologous polypeptides, 
sharing 66% of their phenyialanine-Iabeled tryptie peptides and having at least 7 out 
of 8 identical residues in their partial N-terminal amino acid sequences (17). 
Recently, Emerson et al. (45) have studied the biosynthesis and turnover of the EB 
polypeptides in homozygous (H-2 k) mice. They find that whereas the E~ chains are 
synthesized more rapidly than E, chains, the E,Ea molecules, once assembled, turn 
over at the same rate. 
We should stress that experiments involving biosynthetic labeling cannot address 
questions involving the total amount of Ia protein expressed by a cell. However, these 
intriguing observations on  the differential labeling of Et~ polypeptides in  F1  mice, 
together with the observations of Emerson et al., underline the fact that the control 
of synthesis of Ia molecules may itself be complex and could possibly be haplotype- 
dependent. 
Thus, the role that Ia molecules play in immune responsiveness may depend not 
only on structural polymorphism and the diversity that can be generated by hybrid 
molecules, but  also on  the  rate  at  which  these  molecules can  be  synthesized and 
turned over. New insights into this problem will undoubtedly be obtained when the 
Ia genes themselves can be examined and their regulatory mechanisms are investi- 
gated. 948  STRUCTURE OF MURINE Ia ANTIGENS 
Summary 
We demonstrate that an invariant  polypeptide, first described by Jones et al.  (21), 
co-immunoprecipitates with our Ia molecules, that its interaction with Ia polypeptides 
varies  with  haplotype,  and  that  it  is  not  a  precursor  of the  A~,  Aa,  E~,  or  Ea 
polypeptides. We also show that the polypeptides that we have previously character- 
ized  are  contaminated  with  very little,  if any,  invariant  protein.  Further,  we have 
used  our  high-pressure  liquid  chromatography  tryptic  peptide  map  technique  to 
formally map the genes encoding A~,  A~,  and  Et~ to the LA  subregion using recom- 
binant  and Fx hybrid mice. 
We thank Dr. J. G. Frelinger for stimulating discussions. 
Received  for publication 3 November 1980. 
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